Published in Mol Ther on January 22, 2016
Molecular Medicine of Pulmonary Arterial Hypertension: From Population Genetics to Precision Medicine and Gene Editing. Am J Respir Crit Care Med (2016) 0.89
Genome Editing in Large Animals. J Equine Vet Sci (2016) 0.76
Sendai virus, an RNA virus with no risk of genomic integration, delivers CRISPR/Cas9 for efficient gene editing. Mol Ther Methods Clin Dev (2016) 0.75
Multiplex genome engineering using CRISPR/Cas systems. Science (2013) 55.53
RNA-guided human genome engineering via Cas9. Science (2013) 48.29
A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science (2012) 48.17
Transformation of yeast. Proc Natl Acad Sci U S A (1978) 46.46
The double-strand-break repair model for recombination. Cell (1983) 31.21
Yeast transformation: a model system for the study of recombination. Proc Natl Acad Sci U S A (1981) 26.54
A TALE nuclease architecture for efficient genome editing. Nat Biotechnol (2010) 26.47
Breaking the code of DNA binding specificity of TAL-type III effectors. Science (2009) 22.33
A simple cipher governs DNA recognition by TAL effectors. Science (2009) 19.99
DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol (2013) 19.99
Genome editing with engineered zinc finger nucleases. Nat Rev Genet (2010) 18.88
High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol (2013) 18.01
An improved zinc-finger nuclease architecture for highly specific genome editing. Nat Biotechnol (2007) 17.80
Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting. Nucleic Acids Res (2011) 16.53
Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc Natl Acad Sci U S A (2012) 16.48
RNA-programmed genome editing in human cells. Elife (2013) 14.82
Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases. Nat Biotechnol (2008) 14.75
Targeting DNA double-strand breaks with TAL effector nucleases. Genetics (2010) 14.49
Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat Biotechnol (2013) 14.28
Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell (2013) 13.37
FLASH assembly of TALENs for high-throughput genome editing. Nat Biotechnol (2012) 12.97
Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain. Proc Natl Acad Sci U S A (1996) 12.25
CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat Biotechnol (2013) 11.35
Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science (2014) 10.43
TAL effectors: customizable proteins for DNA targeting. Science (2011) 9.47
Structure-based redesign of the dimerization interface reduces the toxicity of zinc-finger nucleases. Nat Biotechnol (2007) 8.88
High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity. Nat Biotechnol (2013) 8.40
A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity. Nucleic Acids Res (2011) 7.93
Xanthomonas AvrBs3 family-type III effectors: discovery and function. Annu Rev Phytopathol (2010) 7.70
Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. N Engl J Med (2014) 7.64
Double-strand break end resection and repair pathway choice. Annu Rev Genet (2011) 7.31
Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo. Nat Biotechnol (2010) 6.55
An unbiased genome-wide analysis of zinc-finger nuclease specificity. Nat Biotechnol (2011) 6.44
Gene targeting using zinc finger nucleases. Nat Biotechnol (2005) 6.24
Introduction of double-strand breaks into the genome of mouse cells by expression of a rare-cutting endonuclease. Mol Cell Biol (1994) 6.08
Enhancing zinc-finger-nuclease activity with improved obligate heterodimeric architectures. Nat Methods (2010) 6.00
Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System. Cell (2015) 5.97
Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype. Nat Biotechnol (2014) 5.71
DNA interrogation by the CRISPR RNA-guided endonuclease Cas9. Nature (2014) 5.70
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nat Biotechnol (2014) 5.69
High-frequency genome editing using ssDNA oligonucleotides with zinc-finger nucleases. Nat Methods (2011) 5.68
Homing endonuclease structure and function. Q Rev Biophys (2005) 5.27
In vivo genome editing using Staphylococcus aureus Cas9. Nature (2015) 5.26
Crystal structure of Cas9 in complex with guide RNA and target DNA. Cell (2014) 5.26
Regulation of DNA repair throughout the cell cycle. Nat Rev Mol Cell Biol (2008) 5.10
A site-specific endonuclease essential for mating-type switching in Saccharomyces cerevisiae. Cell (1983) 5.05
Recognition and cleavage site of the intron-encoded omega transposase. Proc Natl Acad Sci U S A (1988) 4.92
In vivo genome editing restores haemostasis in a mouse model of haemophilia. Nature (2011) 4.81
Orthogonal Cas9 proteins for RNA-guided gene regulation and editing. Nat Methods (2013) 4.61
Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing. Nat Biotechnol (2014) 4.41
Engineering polydactyl zinc-finger transcription factors. Nat Biotechnol (2002) 4.40
CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activity. Nucleic Acids Res (2013) 4.11
Tracking genome engineering outcome at individual DNA breakpoints. Nat Methods (2011) 4.05
Engineered CRISPR-Cas9 nucleases with altered PAM specificities. Nature (2015) 3.77
The discovery of zinc fingers and their applications in gene regulation and genome manipulation. Annu Rev Biochem (2010) 3.75
Fusion of catalytically inactive Cas9 to FokI nuclease improves the specificity of genome modification. Nat Biotechnol (2014) 3.72
Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease. Nature (2014) 3.72
An intron-encoded protein is active in a gene conversion process that spreads an intron into a mitochondrial gene. Cell (1985) 3.70
The crystal structure of TAL effector PthXo1 bound to its DNA target. Science (2012) 3.69
Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining. Nat Biotechnol (2015) 3.64
Structural basis for sequence-specific recognition of DNA by TAL effectors. Science (2012) 3.64
Cytosolic sensing of viruses. Immunity (2013) 3.54
Synergy between adjacent zinc fingers in sequence-specific DNA recognition. Proc Natl Acad Sci U S A (1997) 3.32
Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins. Genome Res (2014) 3.31
Low incidence of off-target mutations in individual CRISPR-Cas9 and TALEN targeted human stem cell clones detected by whole-genome sequencing. Cell Stem Cell (2014) 3.16
Rationally engineered Cas9 nucleases with improved specificity. Science (2015) 3.14
A rapid, generally applicable method to engineer zinc fingers illustrated by targeting the HIV-1 promoter. Nat Biotechnol (2001) 3.12
Non-viral vectors for gene-based therapy. Nat Rev Genet (2014) 3.04
Genome-wide detection of DNA double-stranded breaks induced by engineered nucleases. Nat Biotechnol (2014) 2.99
CRISPR-Cas systems: Prokaryotes upgrade to adaptive immunity. Mol Cell (2014) 2.87
FokI requires two specific DNA sites for cleavage. J Mol Biol (2001) 2.83
Optimization of scarless human stem cell genome editing. Nucleic Acids Res (2013) 2.78
Effect of genome size on AAV vector packaging. Mol Ther (2009) 2.77
Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells. Nat Biotechnol (2015) 2.77
Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo. Nat Biotechnol (2014) 2.75
Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery. Elife (2014) 2.65
Whole-genome sequencing analysis reveals high specificity of CRISPR/Cas9 and TALEN-based genome editing in human iPSCs. Cell Stem Cell (2014) 2.57
Meganucleases and DNA double-strand break-induced recombination: perspectives for gene therapy. Curr Gene Ther (2007) 2.56
Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR/Cas9. Cell Stem Cell (2014) 2.55
Comprehensive DNA recognition through concerted interactions from adjacent zinc fingers. Biochemistry (1998) 2.51
Targeted genome editing in human repopulating haematopoietic stem cells. Nature (2014) 2.49
Homing endonucleases: from microbial genetic invaders to reagents for targeted DNA modification. Structure (2011) 2.43
Therapeutic genome editing: prospects and challenges. Nat Med (2015) 2.42
Digenome-seq: genome-wide profiling of CRISPR-Cas9 off-target effects in human cells. Nat Methods (2015) 2.29
Engineered zinc finger nickases induce homology-directed repair with reduced mutagenic effects. Nucleic Acids Res (2012) 2.26
Overcoming transcription activator-like effector (TALE) DNA binding domain sensitivity to cytosine methylation. J Biol Chem (2012) 2.25
Iterative capped assembly: rapid and scalable synthesis of repeat-module DNA such as TAL effectors from individual monomers. Nucleic Acids Res (2012) 2.09
A ligation-independent cloning technique for high-throughput assembly of transcription activator–like effector genes. Nat Biotechnol (2013) 1.98
Autonomous zinc-finger nuclease pairs for targeted chromosomal deletion. Nucleic Acids Res (2010) 1.92
Nucleotide-resolution DNA double-strand break mapping by next-generation sequencing. Nat Methods (2013) 1.88
Homing endonucleases: structure, function and evolution. Cell Mol Life Sci (1999) 1.85
Adenoviral vector DNA for accurate genome editing with engineered nucleases. Nat Methods (2014) 1.74
Chromosomal translocations in human cells are generated by canonical nonhomologous end-joining. Mol Cell (2014) 1.72
Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells. Nat Biotechnol (2015) 1.71
Permanent alteration of PCSK9 with in vivo CRISPR-Cas9 genome editing. Circ Res (2014) 1.58
Sequence determinants of improved CRISPR sgRNA design. Genome Res (2015) 1.56
Small molecules enhance CRISPR genome editing in pluripotent stem cells. Cell Stem Cell (2015) 1.49
Generation of knock-in primary human T cells using Cas9 ribonucleoproteins. Proc Natl Acad Sci U S A (2015) 1.49
High-resolution profiling of homing endonuclease binding and catalytic specificity using yeast surface display. Nucleic Acids Res (2009) 1.43
Genome editing technologies: defining a path to clinic. Mol Ther (2015) 1.41